HOUSTON (AP) _ Bellicum Pharmacueticals Inc. (BLCM) on Wednesday reported a loss of $32 million in its third quarter.
The Houston-based company said it had a loss of 68 cents per share. Losses, adjusted for non-recurring costs, were 58 cents per share.
The drug developer posted revenue of $103,000 in the period.
In the final minutes of trading on Wednesday, the company's shares hit $1.28. A year ago, they were trading at $4.52.